ROCHESTER, N.Y., May 23 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. , a leading developer of image-related biomarkers, announced today that Edward Ashton, PhD, its chief scientific officer, was a key presenter at the International Congress of Imaging Science 2006 (ICIS 06) annual meeting (May 7-12, 2006), in Rochester, New York. ICIS, sponsored by the Society for Imaging Science and Technology and several international imaging societies, brings together imaging scientists and technologists from around the world to share the latest in imaging technology innovations.
Dr. Ashton's presentation entitled Quantitative Medical Imaging was featured in the "Frontiers in Imaging" session of the conference, and reviewed developments in the transition from qualitative interpretation of medical images acquired through varying technologies (i.e., CT, MRI, PET) to more rigorous quantitative measurement and analysis. Dr. Ashton cited examples of quantitative research conducted by VirtualScopics to more precisely measure sinus cavity tumors, lesions in the brains of multiple sclerosis patients, progression of disease in osteoarthritis patients and changes in blood flow to tumors.
"Our research demonstrates that a more rigorous and quantitative approach to analyzing medical images holds great promise for clinical trials and many of our pharmaceutical company partners agree," said Bob Klimasewski, president and chief executive officer of VirtualScopics. "We can now assess efficacy or futility of a drug compound earlier in the clinical trial cycle, allowing our customers to make better decisions about which compounds to fund or terminate, getting promising drugs to market and to the patients who need them sooner."
About VirtualScopics, Inc.
VirtualScopics, Inc. is a provider of advanced medical image analysis services. The company evolved from research first carried out at the University of Rochester Medical Center and School of Engineering. VirtualScopics has created a suite of image analysis tools used in detecting and analyzing specific structures in volumetric medical images, as well as characterizing minute changes in structures over time, providing vital information to support clinical trials and diagnostic applications. The firm's proprietary software algorithms can assemble hundreds of separate medical images taken during an MRI session into a single, three-dimensional model, bringing a new and previously unobtainable source of data to clinical researchers. For more information about VirtualScopics, visit www.virtualscopics.com.
Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission.
CONTACT: Tracy Bagatelle-Black Bagatelle-Black Public Relations 661/263-1842 tracy@bagatelleblack.com
VirtualScopics, Inc.CONTACT: Tracy Bagatelle-Black of Bagatelle-Black Public Relations,+1-661-263-1842, or tracy@bagatelleblack.com, for VirtualScopics, Inc.
Web site: http://www.virtualscopics.com/
